Eisai Pans Germany's Fycompa Rejection But Probably Won't Go To Court
This article was originally published in The Pink Sheet Daily
Executive Summary
After Germany’s reimbursement watchdog G-BA vehemently rejected Eisai's criticism of its negative decision on Fycompa, the Japanese company fired back angrily – but it is unlikely to launch a legal challenge.